Edward Nash
Stock Analyst at Canaccord Genuity
(2.56)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MDGL Madrigal Pharmaceuti... | Maintains: Strong Buy | 420 428 | 349.43 | 22.49% | 10 | Aug 6, 2025 | |
CORT Corcept Therapeutics | Maintains: Buy | 142 137 | 71.95 | 90.41% | 8 | Aug 1, 2025 | |
SGMT Sagimet Biosciences | Initiates Coverage On: Buy | 28 | 8.72 | 221.1% | 1 | Jul 24, 2025 | |
VRNA Verona Pharma | Downgrades: Hold | 107 | 105.25 | 1.66% | 10 | Jul 9, 2025 | |
CLDX Celldex Therapeutics | Initiates Coverage On: Buy | 64 | 20.01 | 219.84% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 45 47 | 17.29 | 171.83% | 10 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 9 | 0.5 | 1700% | 2 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 4 | 1.69 | 136.69% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 56 73 | 48.32 | 51.08% | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 89 | 34.58 | 157.37% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 14 | 2.67 | 424.34% | 6 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 8 | 1.01 | 692.08% | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 20 | 3.52 | 468.18% | 2 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 68 66 | 56.99 | 15.81% | 2 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 19 | 19 | 0% | 9 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Hold | 8 | 3.2 | 150% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 71 48 | 47.55 | 0.95% | 3 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 17 | 5.93 | 186.68% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3 2 | 2.09 | -4.31% | 4 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 17 | 14.7 | 15.65% | 2 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 900 180 | 1.45 | 12313.79% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 52 | 51.99 | 0.02% | 2 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | n/a | n/a | 1 | Apr 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 1 | 0.58 | 72.41% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 82 | 27.39 | 199.38% | 5 | Jun 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 120 80 | 2.23 | 3487.44% | 3 | Sep 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 3 | n/a | n/a | 1 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Oct 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 48 | 14.13 | 239.7% | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 650 | 6.28 | 10250.32% | 1 | Nov 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 150 0 | n/a | n/a | 3 | Sep 22, 2017 |